Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemoxacin vs roxadustat in HIF-PHI–treated PD-CKD anemia
ChiCTR2600123440Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pemoxatide in anaemia (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Change in hemoglobin from baseline at week 16. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
pemoxatide
03
Conditions
anaemia
Beyond the preview
Go deeper on ChiCTR2600123440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123440.